Platelet Rich Plasma in Gynecology—Discovering Undiscovered—Review

Dominika Streit-Ciećkiewicz, Aleksandra Kołodyńska, Karolina Futyma-Gąbka, Magdalena Emilia Grzybowska, Jakub Gołacki and Konrad Futyma
Additional contact information
Dominika Streit-Ciećkiewicz: 2nd Department of Gynecology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland
Aleksandra Kołodyńska: 2nd Department of Gynecology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland
Karolina Futyma-Gąbka: Department of Dental and Maxillofacial Radiology, Medical University of Lublin, ul. Chodźki 6, 20-093 Lublin, Poland
Magdalena Emilia Grzybowska: Department of Gynecology, Gynecologic Oncology and Gynecologic Endocrinology, Medical University of Gdańsk, Smoluchowskiego 17, 80-214 Gdańsk, Poland
Jakub Gołacki: 2nd Department of Gynecology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland
Konrad Futyma: 2nd Department of Gynecology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland

IJERPH, 2022, vol. 19, issue 9, 1-11

Abstract: Regenerative medicine combines elements of tissue engineering and molecular biology aiming to support the regeneration and repair processes of damaged tissues, cells and organs. The most commonly used preparation in regenerative medicine is platelet rich plasma (PRP) containing numerous growth factors present in platelet granularities. This therapy is increasingly used in various fields of medicine. This article is a review of literature on the use of PRP in gynecology and obstetrics. There is no doubt that the released growth factors and proteins have a beneficial effect on wound healing and regeneration processes. So far, its widest application is in reproductive medicine, especially in cases of thin endometrium, Asherman’s syndrome, or premature ovarian failure (POF) but also in wound healing and lower urinary tract symptoms (LUTS), such as urinary incontinence or recurrent genitourinary fistula auxiliary treatment. Further research is, however, needed to confirm the effectiveness and the possibility of its application in many other disorders.

Keywords: platelet rich plasma; platelet rich fibrin; vesicovaginal fistula; Asherman’s syndrome; premature ovarian failure; urogynecology (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/9/5284/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/9/5284/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:9:p:5284-:d:802906

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().